FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert de Man

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Hepatitis B virus

Concepts & Ideas

Co-author Network

Publications

TOP 3
Caroline D M Witjes; Robert A de Man; Roy S Dwarkasing; Dik J Kwekkeboom; Cornelis Verhoef; Jan N M Ijzermans
Is bone scintigraphy indicated in surgical work-up for hepatocellular carcinoma patients?
Vania Baptista Lopes; Martin Schutten; Robert A de Man; Theodora E M S de Vries-Sluijs; Abdel El Barzouhi; Bettina E Hansen; Robert J Hassing; Marchina E Van Der Ende
Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.
Ludi Koning; Albert D M E Osterhaus; Suzan D Pas; Fiebo J ten Kate; Aggie H M M Balk; Robert J de Knegt; Robert A de Man; Annemiek A van der Eijk
Clinical implications of chronic hepatitis E virus infection in heart transplant recipients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert de Man (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Caroline D M Witjes; Robert A de Man; Roy S Dwarkasing; Dik J Kwekkeboom; Cornelis Verhoef; Jan N M Ijzermans
Is bone scintigraphy indicated in surgical work-up for hepatocellular carcinoma patients?
The Journal of surgical research 2013;181(2):256-61.
2013: Vania Baptista Lopes; Martin Schutten; Robert A de Man; Theodora E M S de Vries-Sluijs; Abdel El Barzouhi; Bettina E Hansen; Robert J Hassing; Marchina E Van Der Ende
Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.
Vaccine 2013;31(7):1040-4.
2013: Ludi Koning; Albert D M E Osterhaus; Suzan D Pas; Fiebo J ten Kate; Aggie H M M Balk; Robert J de Knegt; Robert A de Man; Annemiek A van der Eijk
Clinical implications of chronic hepatitis E virus infection in heart transplant recipients.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2013;32(1):78-85.
2012: Jerome Sint Nicolaas; Mark F J Stolk; Frank ter Borg; Roland M Valori; Monique E van Leerdam; Antonie J P van Tilburg; Djuna L Cahen; Vincent de Jonge; Robert A de Man; Ernst J Kuipers; Willem Moolenaar
The Global Rating Scale in clinical practice: a comprehensive quality assurance programme for endoscopy departments.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2012;44(11):919-24.
2012: Caroline D M Witjes; Robert A de Man; Roy S Dwarkasing; Fiebo J W Ten Kate; Susanna M van Aalten; Cornelis Verhoef; François E J A Willemssen; Jan N M Ijzermans
Hepatocellular adenoma as a risk factor for hepatocellular carcinoma in a non-cirrhotic liver: a plea against.
Gut 2012;61(11):1645-6.
2012: Roeland Zoutendijk; Robert A de Man; Theodora E M S de Vries-Sluijs; Bettina E Hansen; Frank P Kroon; Jan W Mulder; Jurrien G P Reijnders; Clemens Richter; Milan J Sonneveld; Annemiek A van der Eijk; Marchina E Van Der Ende; Hans L Zaaijer; Harry L A Janssen
Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIV.
The Journal of infectious diseases 2012;206(6):974-80.
2012: Caroline D M Witjes; Robert A de Man; Bettina E Hansen; Sacha J van der Veer; Joanne Verheij; Cornelis Verhoef; François E J A Willemssen; Jan N M Ijzermans
Histological differentiation grade and microvascular invasion of hepatocellular carcinoma predicted by dynamic contrast-enhanced MRI.
Journal of magnetic resonance imaging : JMRI 2012;36(3):641-7.
2012: S M van Aalten; Robert A de Man; J N M IJzermans; Türkan Terkivatan
Systematic review of haemorrhage and rupture of hepatocellular adenomas.
The British journal of surgery 2012;99(7):911-6.
2012: Caroline D M Witjes; Wojciech G Polak; Joanne Verheij; Cornelis Verhoef; Robert A de Man; Roy S Dwarkasing; Ferry A L M Eskens; Jan N M Ijzermans
Increased Alpha-Fetoprotein Serum Level is Predictive for Survival and Recurrence of Hepatocellular Carcinoma in Non-Cirrhotic Livers.
Digestive surgery 2012;29(6):522-8.
2012: Mirelle E E Bröker; Robert A de Man; Jan N M Ijzermans; Susanna M van Aalten; Türkan Terkivatan
The management of pregnancy in women with hepatocellular adenoma: a plea for an individualized approach.
International journal of hepatology 2012;2012():725735.
2012: Mirelle E E Bröker; Roy S Dwarkasing; Jan N M Ijzermans; Eric A P Steegers; Susanna M van Aalten; Robert A de Man
[Hepatocellular adenomas and pregnancy].
Nederlands tijdschrift voor geneeskunde 2012;156(38):A5102.
2012: Susanna M van Aalten; Eric A P Steegers; Ewout W Steyerberg; Türkan Terkivatan; Mirelle E E Bröker; J J V Busschbach; Harry J de Koning; Robert A de Man; Jan N M Ijzermans
Pregnancy and liver adenoma management: PALM-study.
BMC gastroenterology 2012;12():82.
2012: Caroline D M Witjes; Otto Visser; Jan Willem W Coebergh; Robert A de Man; Esther de Vries; Jan N M Ijzermans; Henrike E Karim-Kos; Sanne A W van den Akker; Cornelis Verhoef
Gallbladder cancer in the Netherlands: incidence, treatment and survival patterns since 1989.
Digestive surgery 2012;29(2):92-8.
2012: M Chrispijn; W Coudyzer; Robert A de Man; H M Dekker; T J G Gevers; Aswin L Hoffmann; Frederik Nevens; Loes van Keimpema; Martijn G H Van Oijen; R Vanslembrouck; J P H Drenth
The long-term outcome of patients with polycystic liver disease treated with lanreotide.
Alimentary pharmacology & therapeutics 2012;35(2):266-74.
2011: C D M Witjes; Bettina E Hansen; J N M IJzermans; Annemiek A van der Eijk; C Verhoef; Robert A de Man
Quantitative HBV DNA and AST are strong predictors for survival after HCC detection in chronic HBV patients.
The Netherlands journal of medicine 2011;69(11):508-13.
2011: Susanna M van Aalten; Joanne Verheij; Robert A de Man; Roy S Dwarkasing; Türkan Terkivatan; Maarten G J Thomeer; Jan N M Ijzermans
Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification.
Radiology 2011;261(1):172-81.
2011: A M C Baven-Pronk; U H Beuers; Gerd Bouma; Johannes T Brouwer; MJ Coenraad; Robert A de Man; J den Ouden; J P H Drenth; Ger H Koek; M M H Lamers; Henk R van Buuren; Aad P van den Berg; K J van Erpecum; C M J van Nieuwkerk; Bart van Hoek
The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes.
Alimentary pharmacology & therapeutics 2011;34(3):335-43.
2011: Susanna M van Aalten; Joanne Verheij; Robert A de Man; Roy S Dwarkasing; Türkan Terkivatan; Jan N M Ijzermans
Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.
Journal of hepatology 2011;55(1):120-5.
2011: Mark G van Vledder; Sanne M van Aalten; Türkan Terkivatan; Robert A de Man; Trude Leertouwer; Jan N M Ijzermans
Safety and efficacy of radiofrequency ablation for hepatocellular adenoma.
Journal of vascular and interventional radiology : JVIR 2011;22(6):787-93.
2011: Theodora E M S de Vries-Sluijs; Bettina E Hansen; Gerard J J van Doornum; Robert H Kauffmann; Eliane M S Leyten; Tania Mudrikova; Kees Brinkman; Jan G den Hollander; Frank P Kroon; Harry L A Janssen; Marchina E Van Der Ende; Robert A de Man
A randomized controlled study of accelerated versus standard hepatitis B vaccination in HIV-positive patients.
The Journal of infectious diseases 2011;203(7):984-91.
2011: Johanna E Noels; Susanna M van Aalten; Dirk J van der Windt; Niels F M Kok; Robert A de Man; Türkan Terkivatan; Jan N M Ijzermans
Management of hepatocellular adenoma during pregnancy.
Journal of hepatology 2011;54(3):553-8.
2011: Loes van Keimpema; Daan B De Koning; Bart van Hoek; Aad P van den Berg; Martijn G H Van Oijen; Robert A de Man; Frederik Nevens; Joost P H Drenth
Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases.
Liver international : official journal of the International Association for the Study of the Liver 2011;31(1):92-8.
2010: Theodora E M S de Vries-Sluijs; Jurriën G P Reijnders; Bettina E Hansen; Hans L Zaaijer; Jan M Prins; Suzan D Pas; Martin Schutten; Andy I M Hoepelman; Clemens Richter; Jan W Mulder; Robert A de Man; Harry L A Janssen; Marchina E Van Der Ende
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus.
Gastroenterology 2010;139(6):1934-41.
2010: Edith M M Kuiper; Karel J van Erpecum; Ulrich Beuers; Bettina E Hansen; H Bing Thio; Robert A de Man; Harry L A Janssen; Henk R van Buuren
The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial.
Hepatology (Baltimore, Md.) 2010;52(4):1334-40.
2010: Angela S W Tjon; Jerome Sint Nicolaas; Jaap Kwekkeboom; Robert A de Man; Geert Kazemier; Hugo W Tilanus; Bettina E Hansen; Luc J van der Laan; Thanyalak Tha-In; Herold J Metselaar
Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2010;16(7):837-46.
2010: Irene K Veldhuijzen; Mehlika Toy; Susan Hahné; ardine de wit; Solko W Schalm; Robert A de Man; Jan Hendrik Richardus
Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.
Gastroenterology 2010;138(2):522-30.
2010: Edith M M Kuiper; Bettina E Hansen; Herold J Metselaar; Robert A de Man; Els B Haagsma; Bart van Hoek; Henk R van Buuren
Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008.
BMC gastroenterology 2010;10():144.
2010: Carlijn D M Witjes; Robert A de Man; Ferry A L M Eskens; Roy S Dwarkasing; Pieter E Zondervan; Cornelis Verhoef; Jan N M Ijzermans
[Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
Nederlands tijdschrift voor geneeskunde 2010;154():A1747.
2010: S M van Aalten; Türkan Terkivatan; Robert A de Man; D J van der Windt; N F M Kok; Roy S Dwarkasing; J N M Ijzermans
Diagnosis and treatment of hepatocellular adenoma in the Netherlands: similarities and differences.
Digestive surgery 2010;27(1):61-7.
2010: Robert G Gish; Ting-Tsung Chang; C-L Lai; Robert A de Man; Adrian Gadano; F Fred Poordad; J Yang; H Brett-Smith; R Tamez
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.
Journal of viral hepatitis 2010;17(1):16-22.
2009: Loes van Keimpema; Frederik Nevens; Ragna Vanslembrouck; Martijn G H Van Oijen; Aswin L Hoffmann; Helena M Dekker; Robert A de Man; Joost P H Drenth
Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.
Gastroenterology 2009;137(5):1661-8.e1-2.
2009: Frederik Jan Fabian van der Sluis; Johanna L Bosch; Türkan Terkivatan; Robert A de Man; Jan N M Ijzermans; M G Myriam Hunink
Hepatocellular adenoma: cost-effectiveness of different treatment strategies.
Radiology 2009;252(3):737-46.
2009: Leonardus Gerardus Matheus Moons; Franciscus Hubertus Joseph Wolfhagen; Rudolf Beukers; Robert A de Man; Geert Jacob Leonard Hubert van Leenders; Henk R van Buuren
A rare cause of large liver cysts.
The American journal of gastroenterology 2009;104(4):1056-8.
2009: Jurriën G P Reijnders; Suzan D Pas; Martin Schutten; Robert A de Man; Harry L A Janssen
Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy.
Journal of hepatology 2009;50(4):674-83.
2009: Leonienke F C Dols; Cornelis Verhoef; Ferry A L M Eskens; Olaf Schouten; Joost Nonner; Wim C J Hop; Alejandra Méndez Romero; Robert A de Man; Edwin van der Linden; Roy S Dwarkasing; Jan N M Ijzermans
[Improvement of 5 year survival rate after liver resection for colorectal metastases between 1984-2006].
Nederlands tijdschrift voor geneeskunde 2009;153(11):490-5.
2009: Irene Veldhuijzen; Ted H M Mes; Maria C Mostert; Hubert G M Niesters; Suzan D Pas; Jolanda Voermans; Robert A de Man; Hannelore M Götz; G J J van Doornum; Jan Hendrik Richardus
An improved approach to identify epidemiological and phylogenetic transmission pairs of source and contact tracing of hepatitis B.
Journal of medical virology 2009;81(3):425-34.
2009: J G P Reijnders; Wim F Leemans; Bettina E Hansen; Suzan D Pas; Robert A de Man; M Schutten; Harry L A Janssen
On-treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeks.
Journal of viral hepatitis 2009;16(2):113-20.
2008: Wim F Leemans; Hubert G M Niesters; Annemiek A van der Eijk; Harry L A Janssen; Solko W Schalm; Robert A de Man
Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
European journal of gastroenterology & hepatology 2008;20(8):773-7.
2008: Indra C van den Bos; Shahid M Hussain; Robert A de Man; pieter zondervan; Jan N M Ijzermans; Gabriel P Krestin
Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation.
Current problems in diagnostic radiology 2008;37(3):104-14.
2008: Indra C van den Bos; Shahid M Hussain; Robert A de Man; pieter zondervan; Jan N M Ijzermans; Anda Preda; Gabriel P Krestin
Magnetic resonance imaging of liver lesions: exceptions and atypical lesions.
Current problems in diagnostic radiology 2008;37(3):95-103.
2008: Geert Kazemier; Herold J Metselaar; Robert A de Man; T C K Tran; T H N Groenland; Hugo W Tilanus
[Liver transplantation with a living donor: the first 3 cases in Rotterdam].
Nederlands tijdschrift voor geneeskunde 2008;152(14):817-21.
2008: Suzan D Pas; Nathalie Tran; Robert A de Man; Chantal P Burghoorn-Maas; Guy Vernet; Hubert G M Niesters
Comparison of reverse hybridization, microarray, and sequence analysis for genotyping hepatitis B virus.
Journal of clinical microbiology 2008;46(4):1268-73.
2008: Lieke Hol; Indra C van den Bos; Shahid M Hussain; pieter zondervan; Robert A de Man
Hepatocellular carcinoma complicating biliary atresia after Kasai portoenterostomy.
European journal of gastroenterology & hepatology 2008;20(3):227-31.
2008: Jolie J Gutteling; Anne-Sophie E Darlington; Harry L A Janssen; Hugo J Duivenvoorden; Jan J V Busschbach; Robert A de Man
Effectiveness of health-related quality-of-life measurement in clinical practice: a prospective, randomized controlled trial in patients with chronic liver disease and their physicians.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2008;17(2):195-205.
2008: M Toy; Irene Veldhuijzen; M C Mostert; Robert A de Man; Jan H Richardus
Transmission routes of hepatitis B virus infection in chronic hepatitis B patients in The Netherlands.
Journal of medical virology 2008;80(3):399-404.
2008: Wim F Leemans; Harry L A Janssen; Hubert G M Niesters; Robert A de Man
Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression.
Journal of viral hepatitis 2008;15(2):108-14.
2008: Theodora E M S de Vries-Sluijs; Bettina E Hansen; G J J van Doornum; Tirza Springeling; Nicole M Evertsz; Robert A de Man; Marchina E Van Der Ende
A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients.
The Journal of infectious diseases 2008;197(2):292-4.
2008: Jolie J Gutteling; Jan J V Busschbach; Robert A de Man; Anne-Sophie E Darlington
Logistic feasibility of health related quality of life measurement in clinical practice: results of a prospective study in a large population of chronic liver patients.
Health and quality of life outcomes 2008;6():97.
2008: Jolie J Gutteling; Robert A de Man; Jan J V Busschbach; Anne-Sophie E Darlington
Quality of health care and patient satisfaction in liver disease: the development and preliminary results of the QUOTE-Liver questionnaire.
BMC gastroenterology 2008;8():25.
2008: Cornelis Verhoef; Herman van Dekken; Leo J Hofland; pieter zondervan; Johannes H W de Wilt; Ronald van Marion; Robert A de Man; Jan N M Ijzermans; C H J van Eijck
Somatostatin receptor in human hepatocellular carcinomas: biological, patient and tumor characteristics.
Digestive surgery 2008;25(1):21-6.
2008: M R Korte; M J van Heerde; Robert A de Man; M H G Betjes
Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia.
The Netherlands journal of medicine 2008;66(1):27-30.
2008: Robert A de Man; Annemiek van der Eijck; Irene Veldhuijzen
New aspects on diagnosis and transmission of hepatitis B in pediatric patients and pregnant women.
Advances in experimental medicine and biology 2008;609():64-71.
2008: E H C J Buster; Hanneke J van Vuuren; pieter zondervan; Herold J Metselaar; Hugo W Tilanus; Robert A de Man
Thiopurine-methyltransferase and inosine triphosphate pyrophosphatase polymorphism in a liver transplant recipient developing nodular regenerative hyperplasia on low-dose azathioprine.
European journal of gastroenterology & hepatology 2008;20(1):68-72.
2008: Martijn J ter Borg; Wim F Leemans; Robert A de Man; Harry L A Janssen
Exacerbation of chronic hepatitis B infection after delivery.
Journal of viral hepatitis 2008;15(1):37-41.
2007: Jolie J Gutteling; Robert A de Man; Jan J V Busschbach; Anne-Sophie E Darlington
Health-related quality of life and psychological correlates in patients listed for liver transplantation.
Hepatology international 2007;1(4):437-43.
2007: JJ Kuiper; Robert A de Man; Henk R van Buuren
Review article: Management of ascites and associated complications in patients with cirrhosis.
Alimentary pharmacology & therapeutics 2007;26 Suppl 2():183-93.
2007: Wim F Leemans; Martijn J ter Borg; Robert A de Man
Review article: Success and failure of nucleoside and nucleotide analogues in chronic hepatitis B.
Alimentary pharmacology & therapeutics 2007;26 Suppl 2():171-82.
2007: Indra C van den Bos; Shahid M Hussain; Roy S Dwarkasing; hans stoop; pieter zondervan; Gabriel P Krestin; Robert A de Man
Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinoma.
The British journal of radiology 2007;80(960):e317-20.
2007: Indra C van den Bos; Shahid M Hussain; Roy S Dwarkasing; Wim C J Hop; pieter zondervan; Robert A de Man; Jan N M Ijzermans; Craig W Walker; Gabriel P Krestin
MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns.
Journal of magnetic resonance imaging : JMRI 2007;26(6):1548-55.
2007: Robert G Gish; Anna S F Lok; Ting-Tsung Chang; Robert A de Man; Adrian Gadano; Jose Sollano; Kwang-Hyub Han; You-Chen Chao; Shou-Dong Lee; Melissa Harris; Joanna Yang; Richard J Colonno; Helena Brett-Smith
Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.
Gastroenterology 2007;133(5):1437-44.
2007: Thanyalak Tha-In; Herold J Metselaar; Hugo W Tilanus; Zwier M A Groothuismink; Ernst J Kuipers; Robert A de Man; Jaap Kwekkeboom
Intravenous immunoglobulins suppress T-cell priming by modulating the bidirectional interaction between dendritic cells and natural killer cells.
Blood 2007;110(9):3253-62.
2007: Robert A de Man
[Hepatitis B and C: in view of the treatment options, priority should be given to reaching the groups at risk].
Nederlands tijdschrift voor geneeskunde 2007;151(43):2365-6.
2007: Dave Sprengers; Renate G van der Molen; Rekha S Binda; Johannes G Kusters; Robert A de Man; Hubert G M Niesters; Solko W Schalm; Harry L A Janssen
In vivo immunization in combination with peg-interferon for chronic hepatitis B virus infection.
Journal of viral hepatitis 2007;14(10):743-9.
2007: JJ Kuiper; Henk R van Buuren; Robert A de Man
Ascites in cirrhosis: a review of management and complications.
The Netherlands journal of medicine 2007;65(8):283-8.
2007: J J Gutteling; Robert A de Man; Jan J V Busschbach; Anne-Sophie E Darlington
Overview of research on health-related quality of life in patients with chronic liver disease.
The Netherlands journal of medicine 2007;65(7):227-34.
2007: Dirk J van der Windt; Niels F M Kok; Robert A de Man; Jan N M Ijzermans
[Diagnosis and treatment of hepatocellular adenoma in the Netherlands: similarities and differences].
Nederlands tijdschrift voor geneeskunde 2007;151(24):1345-51.
2007: Wim F Leemans; Harry L A Janssen; Robert A de Man
Future prospectives for the management of chronic hepatitis B.
World journal of gastroenterology : WJG 2007;13(18):2554-67.
2007: E H C J Buster; Annemiek A van der Eijk; Robert A de Man; Harry L A Janssen; Solko W Schalm
Prolonged antiviral therapy for hepatitis B virus-infected health care workers: a feasible option to prevent work restriction without jeopardizing patient safety.
Journal of viral hepatitis 2007;14(5):350-4.
2007: Simone M van der Plas; Bettina E Hansen; Josien B de Boer; Theo Stijnen; Jan Passchier; Robert A de Man; Solko W Schalm
Generic and disease-specific health related quality of life of liver patients with various aetiologies: a survey.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(3):375-88.
2007: P H G M Stadhouders; JJ Kuiper; Henk R van Buuren; Robert A de Man
[Spontaneous bacterial peritonitis, a severe complication in patients with liver cirrhosis].
Nederlands tijdschrift voor geneeskunde 2007;151(9):509-13.
2007: Martijn J ter Borg; Bettina E Hansen; Eva Herrmann; Stefan Zeuzem; YILMAZ CAKALOGLU; Selim Karayalcin; Robert Flisiak; Annemarie van' t Veen; Robert A de Man; Solko W Schalm; Harry La Janssen; Bart L Haagmans
Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.
Antiviral therapy 2007;12(8):1285-94.
2006: Dirk J van der Windt; Niels F M Kok; Shahid M Hussain; pieter zondervan; Ian P J Alwayn; Robert A de Man; Jan N M Ijzermans
Case-orientated approach to the management of hepatocellular adenoma.
The British journal of surgery 2006;93(12):1495-502.
2006: Hajo J Flink; Bettina E Hansen; E Jenny Heathcote; S Victor Feinman; Halis Simsek; Selim Karayalcin; Tomasz Mach; Wim F Leemans; Robert A de Man; Elke Verhey; Solko W Schalm; Harry L A Janssen
Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudine.
The American journal of gastroenterology 2006;101(11):2523-9.
2006: Indra C van den Bos; Shahid M Hussain; Türkan Terkivatan; pieter zondervan; Robert A de Man
Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging.
Journal of magnetic resonance imaging : JMRI 2006;24(5):1071-80.
2006: Türkan Terkivatan; Indra C van den Bos; Shahid M Hussain; Piotr A Wielopolski; Robert A de Man; Jan N M Ijzermans
Focal nodular hyperplasia: lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study.
Journal of magnetic resonance imaging : JMRI 2006;24(4):864-72.
2006: Martijn J ter Borg; Monika van Zonneveld; Stefan Zeuzem; Hakan Senturk; Ulus Akarca; Christopher Simon; Bettina E Hansen; Bart L Haagmans; Robert A de Man; Solko W Schalm; Harry L A Janssen
Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: relation to treatment response.
Hepatology (Baltimore, Md.) 2006;44(3):721-7.
2006: Esmé Waanders; René H M Te Morsche; Robert A de Man; J B M J Jansen; Joost P H Drenth
Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.
Human mutation 2006;27(8):830.
2006: Dave Sprengers; Renate G van der Molen; Johannes G Kusters; Robert A de Man; Hubert G M Niesters; Solko W Schalm; Harry L A Janssen
Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans.
Journal of hepatology 2006;45(2):182-9.
2006: Thanyalak Tha-In; Herold J Metselaar; Hugo W Tilanus; P P C Boor; Shanta Mancham; Ernst J Kuipers; Robert A de Man; Jaap Kwekkeboom
Superior immunomodulatory effects of intravenous immunoglobulins on human T-cells and dendritic cells: comparison to calcineurin inhibitors.
Transplantation 2006;81(12):1725-34.
2006: J J Gutteling; Robert A de Man; Simone M van der Plas; Solko W Schalm; Jan J V Busschbach; Anne-Sophie E Darlington
Determinants of quality of life in chronic liver patients.
Alimentary pharmacology & therapeutics 2006;23(11):1629-35.
2006: JJ Kuiper; Robert A de Man; Henk R van Buuren
[Hepatic hydrothorax].
Nederlands tijdschrift voor geneeskunde 2006;150(21):1157-61.
2006: Monika van Zonneveld; pieter zondervan; YILMAZ CAKALOGLU; Christopher Simon; Ulus Akarca; Thomas M K So; Hajo J Flink; Robert A de Man; Solko W Schalm; Harry L A Janssen
Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(4):399-405.
2006: T E M S de Vries-Sluijs; Annemiek A van der Eijk; Bettina E Hansen; A D M E Osterhaus; Robert A de Man; Marchina E Van Der Ende
Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(1):60-3.
2006: Wim F Leemans; Hajo J Flink; Harry L A Janssen; Hubert G M Niesters; Solko W Schalm; Robert A de Man
The effect of pegylated interferon-alpha on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection.
Journal of hepatology 2006;44(3):507-11.
2006: Hajo J Flink; Monika van Zonneveld; Bettina E Hansen; Robert A de Man; Solko W Schalm; Harry L A Janssen
Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype.
The American journal of gastroenterology 2006;101(2):297-303.
2006: Annemiek A van der Eijk; Hubert G M Niesters; Bettina E Hansen; Rudolf Heijtink; Harry L A Janssen; Solko W Schalm; Robert A de Man
Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.
Journal of viral hepatitis 2006;13(2):96-103.
2006: Türkan Terkivatan; Shahid M Hussain; Robert A de Man; Jan N M Ijzermans
Diagnosis and treatment of benign focal liver lesions.
Scandinavian journal of gastroenterology. Supplement 2006;(243):102-15.
2006: Annemiek A van der Eijk; Robert A de Man; Hubert G M Niesters; Solko W Schalm; H L Zaaijer
Hepatitis B virus (HBV) DNA levels and the management of HBV-infected health care workers.
Journal of viral hepatitis 2006;13(1):2-4.
2005: Hubert G M Niesters; Suzan D Pas; Robert A de Man
Detection of hepatitis B virus genotypes and mutants: current status.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;34 Suppl 1():S4-8.
2005: Annemiek A van der Eijk; Hubert G M Niesters; Bettina E Hansen; Suzan D Pas; Jan H Richardus; Marijke Mostert; Harry L A Janssen; Solko W Schalm; Robert A de Man
Paired, quantitative measurements of hepatitis B virus DNA in saliva, urine and serum of chronic hepatitis B patients.
European journal of gastroenterology & hepatology 2005;17(11):1173-9.
2005: Hajo J Flink; Dave Sprengers; Bettina E Hansen; Monika van Zonneveld; Robert A de Man; Solko W Schalm; Harry L A Janssen
Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy.
Gut 2005;54(11):1604-9.
2005: Jaap Kwekkeboom; Thanyalak Tha-In; Wendy M W Tra; Wim Hop; P P C Boor; Shanta Mancham; pieter zondervan; A C T M Vossen; Johannes G Kusters; Robert A de Man; Herold J Metselaar
Hepatitis B immunoglobulins inhibit dendritic cells and T cells and protect against acute rejection after liver transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(10):2393-402.
2005: Dave Sprengers; Renate G van der Molen; Johannes G Kusters; Jaap Kwekkeboom; Luc J van der Laan; Hubert G M Niesters; Ernst J Kuipers; Robert A de Man; Solko W Schalm; Harry L A Janssen
Flow cytometry of fine-needle-aspiration biopsies: a new method to monitor the intrahepatic immunological environment in chronic viral hepatitis.
Journal of viral hepatitis 2005;12(5):507-12.
2005: Annemiek A van der Eijk; Bettina E Hansen; Hubert G M Niesters; Harry L A Janssen; M van de Ende; Solko W Schalm; Robert A de Man
Viral dynamics during tenofovir therapy in patients infected with lamivudine-resistant hepatitis B virus mutants.
Journal of viral hepatitis 2005;12(4):364-72.
2005: Thjon J Tang; Jaap Kwekkeboom; Shanta Mancham; Rekha S Binda; Robert A de Man; Solko W Schalm; Johannes G Kusters; Harry L A Janssen
Intrahepatic CD8+ T-lymphocyte response is important for therapy-induced viral clearance in chronic hepatitis B infection.
Journal of hepatology 2005;43(1):45-52.
2005: Monika van Zonneveld; Hajo J Flink; Elke Verhey; Hakan Senturk; Stefan Zeuzem; Ulus Akarca; YILMAZ CAKALOGLU; Christopher Simon; Thomas M K So; Guido Gerken; Robert A de Man; Bettina E Hansen; Solko W Schalm; Harry L A Janssen
The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation.
Alimentary pharmacology & therapeutics 2005;21(9):1163-71.
2005: Sjoerd de Rave; Bettina E Hansen; Theo H N Groenland; Geert Kazemier; Robert A de Man; Herold J Metselaar; Onno T Terpstra; Hugo W Tilanus; Jan H N M Ijzermans; Solko W Schalm
Heterotopic vs. orthotopic liver transplantation for chronic liver disease: a case-control comparison of short-term and long-term outcomes.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005;11(4):396-401.
2005: Patrizia Carotenuto; Debby van Riel; André Artsen; Sven Bruijns; Fons G Uytdehaag; Jon D Laman; Andeltje B van Nunen; pieter zondervan; Robert A de Man; Albert D Osterhaus; Oscar Pontesilli
Antiviral treatment with alpha interferon up-regulates CD14 on liver macrophages and its soluble form in patients with chronic hepatitis B.
Antimicrobial agents and chemotherapy 2005;49(2):590-9.
2005: Suzan D Pas; Suwanna Noppornpanth; Annemiek A van der Eijk; Robert A de Man; Hubert G M Niesters
Quantification of the newly detected lamivudine resistant YSDD variants of Hepatitis B virus using molecular beacons.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;32(2):166-72.
2005: Harry L A Janssen; Monika van Zonneveld; Hakan Senturk; Stefan Zeuzem; Ulus Akarca; YILMAZ CAKALOGLU; Christopher Simon; Thomas M K So; Guido Gerken; Robert A de Man; Hubert G M Niesters; pieter zondervan; Bettina Hansen; Solko W Schalm
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.
Lancet 2005;365(9454):123-9.
2005: Herman van Dekken; Cornelis Verhoef; Josiane C Wink; Ronald van Marion; Kees J Vissers; Wim C J Hop; Robert A de Man; Jan N M Ijzermans; C H J van Eijck; pieter zondervan
Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis.
Acta histochemica 2005;107(3):161-71.
2004: Pieter Honkoop; Geert Kazemier; R M Perenboom; M E van de Ende; Robert A de Man
[Liver transplantation in a HIV-positive patient receiving potent antiretroviral therapy; the first case in The Netherlands].
Nederlands tijdschrift voor geneeskunde 2004;148(50):2500-4.
2004: Robert A de Man; Henk R van Buuren; W C J Hop
A randomised study on the efficacy and safety of an automated Tru-Cut needle for percutaneous liver biopsy.
The Netherlands journal of medicine 2004;62(11):441-5.
2004: Maria Catharina Mostert; Jan H Richardus; Robert A de Man
Referral of chronic hepatitis B patients from primary to specialist care: making a simple guideline work.
Journal of hepatology 2004;41(6):1026-30.
2004: Simone M van der Plas; Bettina E Hansen; Josien B de Boer; Theo Stijnen; Jan Passchier; Robert A de Man; Solko W Schalm
The Liver Disease Symptom Index 2.0; validation of a disease-specific questionnaire.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2004;13(8):1469-81.
2004: Oscar Pontesilli; Andeltje B van Nunen; Debby van Riel; Patrizia Carotenuto; Hubert G M Niesters; Fons G Uytdehaag; Robert A de Man; Albert D Osterhaus
Hepatitis B virus-specific T cell response in chronic hepatitis B patients treated with lamivudine and interferon-alpha.
Liver international : official journal of the International Association for the Study of the Liver 2004;24(4):308-15.
2004: Harry L A Janssen; Monika van Zonneveld; Andeltje B van Nunen; Hubert G M Niesters; Solko W Schalm; Robert A de Man
Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome.
European journal of gastroenterology & hepatology 2004;16(8):801-7.
2004: Monika van Zonneveld; Pieter Honkoop; Bettina E Hansen; Hubert G M Niesters; Sarwa Darwish Murad; Robert A de Man; Solko W Schalm; Harry L A Janssen
Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
Hepatology (Baltimore, Md.) 2004;39(3):804-10.
2004: Dimitri A Breems; Pieter Sonneveld; Robert A de Man; Frank W G Leebeek
Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion.
European journal of haematology 2004;72(3):181-5.
2004: Annemiek A van der Eijk; Hubert G M Niesters; Hannelore M Götz; Harry L A Janssen; Solko W Schalm; Albert D M E Osterhaus; Robert A de Man
Paired measurements of quantitative hepatitis B virus DNA in saliva and serum of chronic hepatitis B patients: implications for saliva as infectious agent.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;29(2):92-4.
2004: Thjon J Tang; Robert A de Man; Johannes G Kusters; Jaap Kwekkeboom; Wim C J Hop; Renate G van der Molen; Solko W Schalm; Harry L A Janssen
Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients.
Journal of medical virology 2004;72(2):215-22.
2004: E H C J Buster; Annemiek A van der Eijk; Robert A de Man; Solko W Schalm
Doctor-to-patient transmission of hepatitis B virus: the potential of antiviral therapy for prevention.
Scandinavian journal of gastroenterology. Supplement 2004;(241):45-9.
2004: Shahid M Hussain; Türkan Terkivatan; pieter zondervan; Esmée Lanjouw; Sjoerd de Rave; Jan N M Ijzermans; Robert A de Man
Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis.
Radiographics : a review publication of the Radiological Society of North America, Inc 2004;24(1):3-17; discussion 18-9.
2003: Simone M van der Plas; Bettina E Hansen; Josien B de Boer; Theo Stijnen; Jan Passchier; Robert A de Man; Solko W Schalm
Generic and disease-specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional study.
BMC gastroenterology 2003;3():33.
2003: Cornelis Verhoef; Raymond G J Pot; Robert A de Man; pieter zondervan; Ernst J Kuipers; Jan N M Ijzermans; Johannes G Kusters
Detection of identical Helicobacter DNA in the stomach and in the non-cirrhotic liver of patients with hepatocellular carcinoma.
European journal of gastroenterology & hepatology 2003;15(11):1171-4.
2003: Thjon J Tang; Harry L A Janssen; Johannes G Kusters; Robert A de Man; Solko W Schalm; Jaap Kwekkeboom
The intrahepatic immune response during chronic hepatitis B infection can be monitored by the fine-needle aspiration biopsy technique.
FEMS immunology and medical microbiology 2003;39(1):69-72.
2003: Marc Willems; K Munte; Jan M Vrolijk; J C Den Hollander; M Böhm; M H Kemmeren; Robert A de Man; Johannes T Brouwer
Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection.
The British journal of dermatology 2003;149(2):390-4.
2003: Cornelis Verhoef; Jan-Willem Kuiper; Joos Heisterkamp; Robert A de Man; Peter M T Pattynama; Jan N M Ijzermans
Interstitial laser coagulation with temporary hepatic artery occlusion for patients with cirrhosis and irresectable hepatoma.
The British journal of surgery 2003;90(8):950-5.
2003: Monika van Zonneveld; Andeltje B van Nunen; Hubert G M Niesters; Robert A de Man; Solko W Schalm; Harry L A Janssen
Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection.
Journal of viral hepatitis 2003;10(4):294-7.
2003: Hans Orlent; Jan M Vrolijk; Robert A de Man; Solko W Schalm
[The treatment of hepatitis C].
Nederlands tijdschrift voor geneeskunde 2003;147(25):1208-13.
2003: Wim van de Vrie; Robert A de Man; Henk R van Buuren; W Rudolph Schouten; Hugo W Tilanus; Herold J Metselaar
Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis.
European journal of gastroenterology & hepatology 2003;15(6):657-63.
2003: Sven J van den Hazel; Herold J Metselaar; Hugo W Tilanus; Jan N M Ijzermans; Theo H N Groenland; Loes Visser; Robert A de Man
Successful liver transplantation in a patient with sickle-cell anaemia.
Transplant international : official journal of the European Society for Organ Transplantation 2003;16(6):434-6.
2003: Thjon J Tang; Jaap Kwekkeboom; Jon D Laman; Hubert G M Niesters; pieter zondervan; Robert A de Man; Solko W Schalm; Harry L A Janssen
The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection.
Journal of viral hepatitis 2003;10(3):159-67.
2003: Pieter Honkoop; Robert A de Man
Entecavir: a potent new antiviral drug for hepatitis B.
Expert opinion on investigational drugs 2003;12(4):683-8.
2003: Andeltje B van Nunen; Bettina E Hansen; Dong Jin Suh; H F Löhr; Liliana Chemello; H Fontaine; J Heathcote; Byung-Cheol Song; Harry L A Janssen; Robert A de Man; Solko W Schalm
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase.
Gut 2003;52(3):420-4.
2003: M C Mostert; J H Richardus; Robert A de Man
[Evaluation of the Rotterdam guideline for referral in case of chronic hepatitis B: improvement possible via a shortening of the referral chain and better distribution of information].
Nederlands tijdschrift voor geneeskunde 2003;147(4):159-63.
2003: Leonieke M M Wolters; C J C Geerlings; L van Dijk; Hubert G M Niesters; Arnold G Vulto; Robert A de Man
Lamivudine plasma levels in chronic hepatitis B patients.
The Netherlands journal of medicine 2003;61(1):9-13.
2003: Herman van Dekken; Josiane C Wink; Janneke C Alers; Robert A de Man; Jan N M Ijzermans; pieter zondervan
Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature.
Acta histochemica 2003;105(1):29-41.
2003: Dave Sprengers; Harry L A Janssen; Jaap Kwekkeboom; Hubert G M Niesters; Robert A de Man; Solko W Schalm
In vivo immunization following virus suppression: a novel approach for inducing immune control in chronic hepatitis B.
Journal of viral hepatitis 2003;10(1):7-9.
2002: Türkan Terkivatan; Wietske W Vrijland; Pieter T den Hoed; Robert A de Man; Shahid M Hussain; Hugo W Tilanus; Jan N M Ijzermans
Size of lesion is not a criterion for resection during management of giant liver haemangioma.
The British journal of surgery 2002;89(10):1240-4.
2002: Leonieke M M Wolters; Bettina E Hansen; Hubert G M Niesters; Robert A de Man
Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine-famciclovir or lamivudine-ganciclovir.
European journal of gastroenterology & hepatology 2002;14(9):1007-11.
2002: Shahid M Hussain; pieter zondervan; Jan N M Ijzermans; Solko W Schalm; Robert A de Man; Gabriel P Krestin
Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation.
Radiographics : a review publication of the Radiological Society of North America, Inc 2002;22(5):1023-36; discussion 1037-9.
2002: Hubert G M Niesters; Robert A de Man; Suzan D Pas; Edwin Fries; Albert D M E Osterhaus
Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapy.
Journal of medical microbiology 2002;51(8):695-9.
2002: Leonieke M M Wolters; Bettina E Hansen; Hubert G M Niesters; Rachel S Levi-Drummer; Avidan U Neumann; Solko W Schalm; Robert A de Man
The influence of baseline characteristics on viral dynamic parameters in chronic hepatitis B patients treated with lamivudine.
Journal of hepatology 2002;37(2):253-8.
2002: Dave Sprengers; T van Gelder; pieter zondervan; Hubert G M Niesters; Harry L A Janssen; Robert A de Man
[Fatal fibrosing cholestatic hepatitis following renal transplantation].
Nederlands tijdschrift voor geneeskunde 2002;146(29):1380-4.
2002: Suzan D Pas; Robert A de Man; Edwin Fries; Albert D M E Osterhaus; Hubert G M Niesters
The dynamics of mutations in the YMDD motif of the hepatitis B virus polymerase gene during and after lamivudine treatment as determined by reverse hybridisation.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2002;25(1):63-71.
2002: Jaap Stoker; Mark G Romijn; Robert A de Man; J T Brouwer; G J Weverling; JM van Muiswinkel; pieter zondervan; Johan S Laméris; Jan N M Ijzermans
Prospective comparative study of spiral computer tomography and magnetic resonance imaging for detection of hepatocellular carcinoma.
Gut 2002;51(1):105-7.
2002: Leonieke M M Wolters; Bettina E Hansen; Hubert G M Niesters; Deborah DeHertogh; Robert A de Man
Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B.
Journal of hepatology 2002;37(1):137-44.
2002: Annemiek A van der Eijk; J K Doorduijn; Harry L A Janssen; Solko W Schalm; Hubert G M Niesters; Robert A de Man
[Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma].
Nederlands tijdschrift voor geneeskunde 2002;146(24):1140-4.
2002: Andeltje B van Nunen; Robert A de Man; Rudolf Heijtink; A C T M Vossen; Solko W Schalm
Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue?
Journal of viral hepatitis 2002;9(3):221-8.
2002: Leonieke M M Wolters; Bettina E Hansen; Hubert G M Niesters; Stefan Zeuzem; Solko W Schalm; Robert A de Man
Viral dynamics in chronic hepatitis B patients during lamivudine therapy.
Liver 2002;22(2):121-6.
2002: Leonieke M M Wolters; Hubert G M Niesters; Bettina E Hansen; Marchina E Van Der Ende; Frank P Kroon; C Richter; Kees Brinkman; Pieter L Meenhorst; Robert A de Man
Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2002;24(3):173-81.
2002: Marc Willems; Herold J Metselaar; Hugo W Tilanus; Solko W Schalm; Robert A de Man
Liver transplantation and hepatitis C.
Transplant international : official journal of the European Society for Organ Transplantation 2002;15(2-3):61-72.
2002: Annemiek A van der Eijk; Hubert G M Niesters; Suzan D Pas; Robert A de Man
Persistence of YMDD variants after withdrawal of Lamivudine.
Journal of hepatology 2002;36(2):304-5.
2002: Sjoerd de Rave; Hugo W Tilanus; Joke van der Linden; Robert A de Man; Bart van der Berg; Wim C J Hop; Jan N M Ijzermans; pieter zondervan; Herold J Metselaar
The importance of orthotopic liver transplantation in acute hepatic failure.
Transplant international : official journal of the European Society for Organ Transplantation 2002;15(1):29-33.
2001: Leonieke M M Wolters; Hubert G M Niesters; Robert A de Man
Nucleoside analogues for chronic hepatitis B.
European journal of gastroenterology & hepatology 2001;13(12):1499-506.
2001: Andeltje B van Nunen; Harry L A Janssen; Leonieke M M Wolters; Hubert G M Niesters; Robert A de Man; Solko W Schalm
Is combination therapy with lamivudine and interferon-alpha superior to monotherapy with either drug?
Antiviral research 2001;52(2):139-46.
2001: Türkan Terkivatan; Johannes H W de Wilt; Robert A de Man; Rick van Rijn; pieter zondervan; Hugo W Tilanus; Jan N M Ijzermans
Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal.
Archives of surgery (Chicago, Ill. : 1960) 2001;136(9):1033-8.
2001: Robert A de Man; Leonieke M M Wolters; F Nevens; D Chua; M Sherman; C L Lai; Adrian Gadano; Y Lee; F Mazzotta; N Thomas; Deborah DeHertogh
Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection.
Hepatology (Baltimore, Md.) 2001;34(3):578-82.
2001: Rudolf Heijtink; Andeltje B van Nunen; PF van Bergen; L Ostberg; Albert D M E Osterhaus; Robert A de Man
Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: monitoring of serum TUVIRUMAB in immune complexes.
Journal of medical virology 2001;64(4):427-34.
2001: G Unal; J B de Boer; G J Borsboom; Johannes T Brouwer; Marie-Louise Essink-Bot; Robert A de Man
A psychometric comparison of health-related quality of life measures in chronic liver disease.
Journal of clinical epidemiology 2001;54(6):587-96.
2001: Andeltje B van Nunen; Oscar Pontesilli; Fons G Uytdehaag; Albert D M E Osterhaus; Robert A de Man
Suppression of hepatitis B virus replication mediated by hepatitis A-induced cytokine production.
Liver 2001;21(1):45-9.
2001: Türkan Terkivatan; Johannes H W de Wilt; Robert A de Man; Rick van Rijn; Hugo W Tilanus; Jan N M Ijzermans
Treatment of ruptured hepatocellular adenoma.
The British journal of surgery 2001;88(2):207-9.
2001: Michel van Agthoven; Herold J Metselaar; Hugo W Tilanus; Robert A de Man; Jan N M Ijzermans; B M Martin van Ineveld
A comparison of the costs and effects of liver transplantation for acute and for chronic liver failure.
Transplant international : official journal of the European Society for Organ Transplantation 2001;14(2):87-94.
2000: Leonieke M M Wolters; Andeltje B van Nunen; Pieter Honkoop; A C T M Vossen; Hubert G M Niesters; pieter zondervan; Robert A de Man
Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus.
Journal of viral hepatitis 2000;7(6):428-34.
2000: P L van Battum; Wim van de Vrie; Herold J Metselaar; V M Verstappen; P E Zondervan; Robert A de Man
[Acute liver failure ascribed to nefazodone: importance of 'postmarketing surveillance' for recently introduced drugs].
Nederlands tijdschrift voor geneeskunde 2000;144(41):1964-7.
2000: pieter zondervan; Josiane C Wink; Janneke C Alers; Jan N M Ijzermans; S W Schalm; Robert A de Man; Herman van Dekken
Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
The Journal of pathology 2000;192(2):207-15.
2000: Pieter Honkoop; Robert A de Man; Hubert G M Niesters; pieter zondervan; Solko W Schalm
Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy.
Hepatology (Baltimore, Md.) 2000;32(3):635-9.
2000: Joos Heisterkamp; Richard van Hillegersberg; Robert A de Man; Hugo W Tilanus; Jan-Willem Kuiper; Peter M T Pattynama; Jan N M Ijzermans
[Treatment of non-resectable liver tumors with percutaneous interstitial laser coagulation while interrupting blood circulation to the liver].
Nederlands tijdschrift voor geneeskunde 2000;144(32):1542-8.
2000: I J Hartmann; M Groeneweg; JC Quero; S J Beijeman; Robert A de Man; Wim C J Hop; Solko W Schalm
The prognostic significance of subclinical hepatic encephalopathy.
The American journal of gastroenterology 2000;95(8):2029-34.
2000: Suzan D Pas; Edwin Fries; Robert A de Man; Albert D M E Osterhaus; Hubert G M Niesters
Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays.
Journal of clinical microbiology 2000;38(8):2897-901.
2000: F ter Borg; Fiebo J W Ten Kate; H Theo M Cuypers; A Leentvaar-Kuijpers; Johannes Oosting; Pauline M E Wertheim-van Dillen; Pieter Honkoop; Marijke C Rasch; Robert A de Man; Jan van Hattum; Robert Chamuleau; G N J Tytgat; E Anthony Jones
A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals.
Journal of clinical pathology 2000;53(7):541-8.
2000: C H van der Vlies; Thjon J Tang; Hubert G M Niesters; P E Zondervan; Harry L A Janssen; Robert A de Man
Acute hepatitis C infection: an indication for alfa interferon therapy?
The Netherlands journal of medicine 2000;57(1):30-3.
2000: Andeltje B van Nunen; Robert A de Man; Rudolf Heijtink; Hubert G M Niesters; Solko W Schalm
Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients.
Journal of hepatology 2000;32(6):1040-1.
2000: N M Soesman; Guus F Rimmelzwaan; Nella J Nieuwkoop; Walter Emil Philipp Beyer; H W Tilanus; M H Kemmeren; Herold J Metselaar; Robert A de Man; Albert D M E Osterhaus
Efficacy of influenza vaccination in adult liver transplant recipients.
Journal of medical virology 2000;61(1):85-93.
2000: Solko W Schalm; Leonieke M M Wolters; Andeltje B van Nunen; Hubert G M Niesters; Robert A de Man
New nucleoside analogues for chronic hepatitis B.
Acta gastro-enterologica Belgica 2000;63(2):191-3.
2000: Türkan Terkivatan; Johannes H W de Wilt; Robert A de Man; Jan N M Ijzermans
Management of hepatocellular adenoma during pregnancy.
Liver 2000;20(2):186-7.
2000: Rudolf Heijtink; PF van Bergen; WP Paulij; Robert A de Man; Albert D M E Osterhaus
Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines.
Vaccine 2000;18(15):1531-8.
2000: Leonieke M M Wolters; Andeltje B van Nunen; Hubert G M Niesters; Robert A de Man
Contrasting patterns of response to lamivudine monotherapy in chronic hepatitis B patients.
Scandinavian journal of gastroenterology. Supplement 2000;(232):74-8.
2000: Thjon J Tang; Harry L A Janssen; C H van der Vlies; Robert A de Man; Herold J Metselaar; Hugo W Tilanus; S de Marie
Aspergillus osteomyelitis after liver transplantation: conservative or surgical treatment?
European journal of gastroenterology & hepatology 2000;12(1):123-6.
1999: Robert A de Man; Pieter Honkoop; H L Janssen; Solko W Schalm
[Chronic hepatitis-b-virus infections: new options for antiviral therapy].
Nederlands tijdschrift voor geneeskunde 1999;143(37):1857-61.
1999: Rudolf Heijtink; WP Paulij; PF van Bergen; MH van Roosmalen; D Rohm; B Eichentopf; E Muchmore; Robert A de Man; Albert D M E Osterhaus
In vivo activity of a mixture of two human monoclonal antibodies (anti-HBs) in a chronic hepatitis B virus carrier chimpanzee.
The Journal of general virology 1999;80 ( Pt 6)():1529-35.
1999: Leonieke M M Wolters; Hubert G M Niesters; Robert A de Man; Solko W Schalm
Antiviral treatment for human immunodeficiency virus patients co-infected with hepatitis B virus: combined effect for both infections, an obtainable goal?
Antiviral research 1999;42(1):71-6.
1998: Robert A de Man; Angeline Bartholomeusz; Hubert G M Niesters; pieter zondervan; S A Locarnini
The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
Journal of hepatology 1998;29(4):669-75.
1998: F ter Borg; Susanne M Smorenburg; Robert A de Man; RC Rietbroek; Robert Chamuleau; E Anthony Jones
Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy.
Digestive diseases and sciences 1998;43(10):2267-70.
1998: Pieter Honkoop; Robert A de Man; Hubert G M Niesters; J Main; Frederik Nevens; Howard Thomas; Johan Fevery; D L Tyrrell; Solko W Schalm
Quantitative hepatitis B virus DNA assessment by the limiting-dilution polymerase chain reaction in chronic hepatitis B patients: evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapy.
Journal of viral hepatitis 1998;5(5):307-12.
1998: Pieter Honkoop; Robert A de Man; Hubert G M Niesters; Solko W Schalm
Clinical impact of lamivudine resistance in chronic hepatitis B.
Journal of hepatology 1998;29(3):510-1.
1998: M Heeringa; Pieter Honkoop; Robert A de Man; J Feenstra; C M Smits
[Major psychiatric side effects of interferon alpha-2b].
Nederlands tijdschrift voor geneeskunde 1998;142(28):1618-21.
1998: F ter Borg; Fiebo J W Ten Kate; H Theo M Cuypers; A Leentvaar-Kuijpers; Johannes Oosting; Pauline M E Wertheim-van Dillen; Pieter Honkoop; Marijke C Rasch; Robert A de Man; Jan van Hattum; Robert Chamuleau; Henk W Reesink; E Anthony Jones
Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen.
Lancet 1998;351(9120):1914-8.
1998: Leonieke M M Wolters; Pieter Honkoop; Hubert G M Niesters; Robert A de Man
Efficacy of famciclovir treatment in chronic hepatitis B patients with different mutations at position 552 of the DNA polymerase gene.
Journal of hepatology 1998;28(5):909-10.
1998: H G Niesters; P Honkoop; E B Haagsma; Robert A de Man; Solko W Schalm; A D Osterhaus
Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment.
The Journal of infectious diseases 1998;177(5):1382-5.
1998: Pieter Honkoop; Robert A de Man; Hubert G M Niesters
Quantitative assessment of hepatitis B virus DNA during a 24-week course of lamivudine therapy.
Annals of internal medicine 1998;128(8):697.
1998: TG van Rossum; Arnold G Vulto; Robert A de Man; Johannes T Brouwer; Solko W Schalm
Review article: glycyrrhizin as a potential treatment for chronic hepatitis C.
Alimentary pharmacology & therapeutics 1998;12(3):199-205.
1998: Albert D M E Osterhaus; M C Vos; A H Balk; Robert A de Man; J W Mouton; PH Rothbarth; S W Schalm; A M Tomaello; Hubert G M Niesters; Henri A Verbrugh
Transmission of hepatitis B virus among heart transplant recipients during endomyocardial biopsy procedures.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1998;17(2):158-66.
1997: Frederik Nevens; J Main; Pieter Honkoop; D L Tyrrell; J Barber; M T Sullivan; Johan Fevery; Robert A de Man; Howard Thomas
Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study.
Gastroenterology 1997;113(4):1258-63.
1997: Pieter Honkoop; Robert A de Man; P E Zondervan; Solko W Schalm
Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine.
Liver 1997;17(2):103-6.
1997: Robert A de Man
[Severe hepatitis attributed to paroxetine (Seroxat)].
Nederlands tijdschrift voor geneeskunde 1997;141(11):540-2.
1995: Robert A de Man; R P Sprey; Hubert G M Niesters; Rudolf Heijtink; P E Zondervan; W Hop; Solko W Schalm
Survival and complications in a cohort of patients with anti-delta positive liver disease presenting in a tertiary referral clinic.
Journal of hepatology 1995;23(6):662-7.
1995: Rudolf Heijtink; J Snobl; J Kruining; C Kerkhof-Los; Robert A de Man; H L Janssen; Solko W Schalm
Quantitative measurement of HBeAg in chronic hepatitis B: a comparison between a radioimmunoassay, a fluorescence ELISA and a chemiluminescence ELISA.
Journal of medical virology 1995;47(3):245-50.
1995: Pieter Honkoop; Robert A de Man; Rudolf Heijtink; Solko W Schalm
Hepatitis B reactivation after lamivudine.
Lancet 1995;346(8983):1156-7.
1995: Rudolf Heijtink; J Kruining; Y A Weber; Robert A de Man; Solko W Schalm
Anti-hepatitis B virus activity of a mixture of two monoclonal antibodies in an "inhibition in solution" assay.
Hepatology (Baltimore, Md.) 1995;22(4 Pt 1):1078-83.
1995: Solko W Schalm; Robert A de Man; Rudolf Heijtink; Hubert G M Niesters
New nucleoside analogues for chronic hepatitis B.
Journal of hepatology 1995;22(1 Suppl):52-6.
1994: Robert A de Man
[Morbidity and mortality caused by use of ecstasy].
Nederlands tijdschrift voor geneeskunde 1994;138(37):1850-5.
1994: Robert A de Man; D J Bac; M van Blankenstein; P E Zondervan
Sterile necrosis of the liver due to primary epithelioid haemangio-endothelioma presenting as fever of undetermined origin.
The Netherlands journal of medicine 1994;45(1):25-9.
1994: F W Leebeek; Robert A de Man; D J Bac
[Hepatitis A; an innocent childhood disease?].
Nederlands tijdschrift voor geneeskunde 1994;138(19):937-40.
1993: Robert A de Man; H J Metselaar; Rudolf Heijtink; Solko W Schalm
Long-term application of human polyclonal hepatitis-B immunoglobulin to prevent hepatic allograft infection. A review of the literature and presentation of five cases.
The Netherlands journal of medicine 1993;43(1-2):74-82.
1993: Robert A de Man; J H Paul Wilson; H S Tjen
[Acute liver failure caused by methylenedioxymethamphetamine ('ecstasy')].
Nederlands tijdschrift voor geneeskunde 1993;137(14):727-9.
1993: H L Janssen; Solko W Schalm; L Berk; Robert A de Man; Rudolf Heijtink
Repeated courses of alpha-interferon for treatment of chronic hepatitis type B.
Journal of hepatology 1993;17 Suppl 3():S47-51.
1993: J N Ijzermans; H W Tilanus; Robert A de Man; H J Metselaar
"Ecstasy" and liver transplantation.
Annales de médecine interne 1993;144(8):568.
1992: F E de Jongh; H L Janssen; Robert A de Man; W C Hop; Solko W Schalm; M van Blankenstein
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver.
Gastroenterology 1992;103(5):1630-5.
1992: H L Janssen; L Berk; Robert A de Man; Rudolf Heijtink; Solko W Schalm
[Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].
Nederlands tijdschrift voor geneeskunde 1992;136(17):835-9.
1992: L Berk; Solko W Schalm; Robert A de Man; R A Heytink; P Berthelot; C Brechot; B Boboc; F Degos; P Marcellin; J P Benhamou
Failure of acyclovir to enhance the antiviral effect of alpha lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B. A multi-centre randomized controlled trial.
Journal of hepatology 1992;14(2-3):305-9.
1991: L Berk; Robert A de Man; Solko W Schalm; R P Labadie; Rudolf Heijtink
Beneficial effects of Phyllanthus amarus for chronic hepatitis B, not confirmed.
Journal of hepatology 1991;12(3):405-6.
1991: L Berk; Robert A de Man; C Housset; P Berthelot; Solko W Schalm
Alpha lymphoblastoid interferon and acyclovir for chronic hepatitis delta.
Progress in clinical and biological research 1991;364():411-20.
1991: Robert A de Man; L Berk; Solko W Schalm; T Stijnen
Treatment of chronic viral hepatitis.
Digestive diseases (Basel, Switzerland) 1991;9(1):17-35.
1989: Robert A de Man; Jan Lindemans; Solko W Schalm; F J ten Kate
beta 2-Microglobulin and antiviral therapy for chronic hepatitis type B.
Antiviral research 1989;11(4):181-90.
1989: Robert A de Man; Solko W Schalm; A J van der Heijden; F W ten Kate; E D Wolff; Rudolf Heijtink
Improvement of hepatitis B-associated glomerulonephritis after antiviral combination therapy.
Journal of hepatology 1989;8(3):367-72.
1988: Robert A de Man; Solko W Schalm; Rudolf Heijtink; L Berk; J Den Ouden; F J ten Kate; Robert Chamuleau; H W Reesink
Long-term follow-up of antiviral combination therapy in chronic hepatitis B.
The American journal of medicine 1988;85(2A):150-4.
1987: Robert A de Man; S W Schalm; R A Heijtink; Robert Chamuleau; H W Reesink; J den Ouden
[Antiviral combination therapy in chronic hepatitis B].
Nederlands tijdschrift voor geneeskunde 1987;131(28):1221-5.
1986: Solko W Schalm; R A Heytink; Henk R van Buuren; Robert A de Man
Lymphoblastoid alpha-interferon weekly, daily and combined with acyclovir for chronic HBeAg-positive hepatitis.
Journal of hepatology 1986;3 Suppl 2():S189-92.
1986: Solko W Schalm; R A Heytink; Henk R van Buuren; Robert A de Man
Acyclovir, oral, intravenous and combined with interferon for chronic HBeAg-positive hepatitis.
Journal of hepatology 1986;3 Suppl 2():S137-41.
1985: Solko W Schalm; R A Heytink; Henk R van Buuren; Robert A de Man
Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B.
Lancet 1985;2(8451):358-60.